YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Prediabetes versus type 2 diabetes in patients with acute myocardial infarction and current smoking	AMERICAN JOURNAL OF THE MEDICAL SCIENCES
2022	Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease	ABDOMINAL RADIOLOGY
2022	Inhibition of lysyl oxidase‑like 2 ameliorates folic acid‑induced renal tubulointerstitial fibrosis	EXPERIMENTAL AND THERAPEUTIC MEDICINE
2022	Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B	LIVER INTERNATIONAL
2022	Nanomedicine for glioblastoma: Progress and future prospects	SEMINARS IN CANCER BIOLOGY
2022	BVAS version 3 and BVAS/GPA: standing on the same line?	CLINICAL RHEUMATOLOGY
2022	Differentially hypomethylated cell-free DNA and coronary collateral circulation	CLINICAL EPIGENETICS
2022	A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis	SCIENTIFIC REPORTS
2022	Developing an app-based self-management program for people living with HIV: a randomized controlled pilot study during the COVID-19 pandemic	SCIENTIFIC REPORTS
2022	EXPLORE-LC: A multi-site real-world evidence research platform for non-small cell lung cancer in Asia-Pacific	ANNALS OF ONCOLOGY
2022	Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World Study	BLOOD
2022	Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052	ANNALS OF ONCOLOGY
2022	Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study	ANNALS OF ONCOLOGY
2022	ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib	ANNALS OF ONCOLOGY
2022	Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722	ANNALS OF ONCOLOGY
2022	The risk of uterine cervical cancer in inflammatory bowel disease: An updated systematic review and meta-analysis	ANNALS OF ONCOLOGY
2022	Amivantamab in combination with lazertinib in patients with atypical epidermal growth factor receptor (EGFR) mutations excluding exon 20 insertion mutations: Initial results from CHRYSALIS-2	ANNALS OF ONCOLOGY
2022	Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial	CIRCULATION
2022	A Potent Small Molecule Inhibitor of FLT3, PHI-101 Overcomes Resistance in Acute Myeloid Leukemia: Efficacy and PK/PD Profile in Phase 1 First in Human Study	BLOOD
2022	A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit	BLOOD